CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease

OBJECTIVE: Symptomatic intracranial atherosclerotic disease (ICAD) has a high risk of recurrent stroke. Genetic polymorphisms in CYP2C19 and CES1 are associated with adverse outcomes in cardiovascular patients, but have not been studied in ICAD. The authors studied CYP2C19 and CES1 single-nucleotide...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Neurosurg
Główni autorzy: Hoh, Brian L., Gong, Yan, McDonough, Caitrin W., Waters, Michael F., Royster, Adrienne J., Sheehan, Tiffany O., Burkley, Ben, Langaee, Taimour Y., Mocco, J, Zuckerman, Scott L., Mummareddy, Nishit, Stephens, Marcus L., Ingram, Christie, Shaffer, Christian M., Denny, Joshua C., Brilliant, Murray H., Kitchner, Terrie E., Linneman, James G., Roden, Dan M., Johnson, Julie A.
Format: Artigo
Język:Inglês
Wydane: 2015
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915569/
https://ncbi.nlm.nih.gov/pubmed/26587656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2015.6.JNS15795
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy